Compare SEB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEB | GRFS |
|---|---|---|
| Founded | 1918 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.9B |
| IPO Year | 1994 | N/A |
| Metric | SEB | GRFS |
|---|---|---|
| Price | $4,555.57 | $7.26 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.15 |
| AVG Volume (30 Days) | 5.1K | ★ 701.4K |
| Earning Date | 05-12-2026 | 07-28-2022 |
| Dividend Yield | 0.17% | ★ 1.80% |
| EPS Growth | ★ 467.71 | N/A |
| EPS | ★ 124.24 | N/A |
| Revenue | ★ $5,809,000,000.00 | N/A |
| Revenue This Year | N/A | $4.49 |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | $37.17 | ★ $18.67 |
| Revenue Growth | ★ 7.99 | N/A |
| 52 Week Low | $2,990.00 | $6.96 |
| 52 Week High | $5,989.37 | $11.14 |
| Indicator | SEB | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 46.95 |
| Support Level | $4,265.35 | $6.96 |
| Resistance Level | $4,800.00 | $7.73 |
| Average True Range (ATR) | 158.52 | 0.17 |
| MACD | 24.19 | 0.03 |
| Stochastic Oscillator | 59.80 | 64.89 |
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.